These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7391940)

  • 1. Pharmacokinetic studies of propoxyphene I:Effect of portacaval shunt on systemic availability in dogs.
    Giacomini KM; Nakeeb SM; Levy G
    J Pharm Sci; 1980 Jul; 69(7):786-9. PubMed ID: 7391940
    [No Abstract]   [Full Text] [Related]  

  • 2. Propoxyphene and norpropoxyphene plasma concentrations after oral propoxyphene in cirrhotic patients with and without surgically constructed portacaval shunt.
    Giacomini KM; Giacomini JC; Gibson TP; Levy G
    Clin Pharmacol Ther; 1980 Sep; 28(3):417-24. PubMed ID: 7408401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ethanol intake on propoxyphene absorption and biotransformation in dogs.
    Olsen H; Aune H; Lilleaasen P; Gulliksen M; Bodd E; Mørland J
    Alcohol Clin Exp Res; 1986 Aug; 10(4):393-6. PubMed ID: 3530016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic studies of propoxyphene IV: Effect of renal failure on systemic clearance in rats.
    Roberts SM; Levy G
    J Pharm Sci; 1980 Mar; 69(3):363-4. PubMed ID: 7381726
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of portacaval shunt on the disposition of drugs with and without first-pass effect.
    Gugler R; Lain P; Azarnoff DL
    J Pharmacol Exp Ther; 1975 Dec; 195(3):416-23. PubMed ID: 1195128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propoxyphene and norpropoxyphene plasma concentrations in the anephric patient.
    Gibson TP; Giacomini KM; Briggs WA; Whitman W; Levy G
    Clin Pharmacol Ther; 1980 May; 27(5):665-70. PubMed ID: 7371364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-propoxyphene and norpropoxyphene kinetics after the oral administration of D-propoxyphene: a new approach to liver function?
    Horsmans Y; Desager JP; Daenens C; Harvengt C; Geubel AP
    J Hepatol; 1994 Sep; 21(3):283-91. PubMed ID: 7836695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Disposition of propoxyphene in children.
    Wilson JT
    Acta Pharm Suec; 1974 Dec; 11(6):651-2. PubMed ID: 1136803
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of first-pass effect on the systemic availability of propoxyphene.
    Perrier D; Gibaldi M
    J Clin Pharmacol New Drugs; 1972; 12(11):449-52. PubMed ID: 4484660
    [No Abstract]   [Full Text] [Related]  

  • 10. Simultaneous estimation of propoxyphene-do and propoxyphene-d2 levels by quantitative mass fragmentography. Potential utility in multidose investigations.
    Sullivan HR; Wood PG; McMahon RE
    Biomed Mass Spectrom; 1976 Oct; 3(5):212-6. PubMed ID: 974235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of propoxyphene.
    Pearson RM
    Hum Toxicol; 1984 Aug; 3 Suppl():37S-40S. PubMed ID: 6480015
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute effect of ethanol on hepatic first-pass elimination of propoxyphene in rats.
    Oguma T; Levy G
    J Pharmacol Exp Ther; 1981 Oct; 219(1):7-13. PubMed ID: 7288618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hemodialysis on propoxyphene and norpropoxyphene concentrations in blood of anephric patients.
    Giacomini KM; Gibson TP; Levy G
    Clin Pharmacol Ther; 1980 Apr; 27(4):508-14. PubMed ID: 7357810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal and fetal blood/brain distribution of d-propoxyphene and norpropoxyphene in rat and dog.
    Due SL; Sullivan HR; Cochrane RL; Page JG; McMahon RE
    Toxicol Appl Pharmacol; 1981 Apr; 58(2):194-202. PubMed ID: 7245195
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma concentrations and electrocardiographic alterations after repetitive administration of propoxyphene to dogs.
    Page JG; Sullivan HR; Due SL; Slater IH
    Toxicol Appl Pharmacol; 1979 Sep; 50(3):505-14. PubMed ID: 516064
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma protein binding of d-propoxyphene in normal subjects and anephric patients.
    Giacomini KM; Gibson TP; Levy G
    J Clin Pharmacol; 1978; 18(2-3):106-9. PubMed ID: 624774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic interaction between substances with opioid effects and ethanol.
    Bodd E
    Pharmacol Toxicol; 1987; 60 Suppl 2():1-40. PubMed ID: 3588531
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma concentrations of propoxyphene in man. II. Pharmacokinetics.
    Wagner JG; Welling PG; Sedman AJ
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):381-8. PubMed ID: 5046052
    [No Abstract]   [Full Text] [Related]  

  • 19. The fate of radiocarbon-labeled propoxyphene in rat, dog, and human.
    McMahon RE; Ridolfo AS; Culp HW; Wolen RL; Marshall FJ
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):427-44. PubMed ID: 5571348
    [No Abstract]   [Full Text] [Related]  

  • 20. Adsorption of propoxyphene hydrochloride by activated charcoal.
    Chernish SM; Wolen RL; Rodda BE
    Clin Toxicol; 1972; 5(3):317-29. PubMed ID: 5073815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.